GPR15 Antibody (367902) [Janelia Fluor® 635]
Novus Biologicals, part of Bio-Techne | Catalog # FAB3654JF635
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-reported, Flow Cytometry
Label
Janelia Fluor 635
Antibody Source
Monoclonal Mouse IgG2B Clone # 367902
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
NS0 mouse myeloma cell line transfected with human GPR15
Met1-Leu360
Accession # P49685
Met1-Leu360
Accession # P49685
Specificity
Stains human GPR15-transfected cells but not irrelevant transfectants.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for GPR15 Antibody (367902) [Janelia Fluor® 635]
Application
Recommended Usage
CyTOF-reported
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: GPR15
Long Name
G Protein-coupled Receptor 15
Alternate Names
Bob
Gene Symbol
GPR15
Additional GPR15 Products
Product Documents for GPR15 Antibody (367902) [Janelia Fluor® 635]
Product Specific Notices for GPR15 Antibody (367902) [Janelia Fluor® 635]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...